AI-generated summary
The authors compared a 660-nm diode laser with a control group in 72 patients with head and neck cancer receiving radiotherapy and chemotherapy, to assess prevention and treatment of oral mucositis. The authors report that laser-group patients usually did not develop oral mucositis or pain, while all control patients did, with differences significant from week 1 through week 7. The authors describe the laser as effective and improving quality of life.
- Participants
- 72
- Who or what was studied
- Patients with head and neck cancer receiving radiotherapy and chemotherapy at a cancer hospital in Mato-Grosso, Brazil
- Wavelengths
- 660 nm
- Limits stated in the abstract
- unclear
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 30 mW
- Total energy
- 2 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Oral mucositis, Low-level laser therapy, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.